Boots has launched a new No7 Beauty Company skincare range, Future Renew, calling it the “biggest cosmetic science innovation” in the brand’s history. 

The new range, developed following 15 years of research, contains a “world-first super-peptide blend” that is proven to reverse signs of skin damage. 

No7 Future Renew is made up of four skincare products that are “proven to harness the skin’s natural repair process and the renewal of over 50 key proteins in skin cells”, said the brand.  

The range will be available to shoppers exclusively at Boots from April 12 and consists of a serum, eye serum, night cream and day cream with SPF40.  

No7’s head of science research Dr Mike Bell said: “Underpinning this landmark innovation is No7’s long-standing research partnership with a team of expert scientists from the University of Manchester. Together we used new state-of-the-art methodologies and techniques such as machine learning and advanced robotics to identify and screen naturally-occurring skin efficacious peptides – a first for the cosmetics industry.

“The result is a brand-new peptide blend which we believe will be a game changer, paving the way for highly effective skincare to be accessible to even more of our customers.” 

No7 Beauty Company managing director Mark Winter said: “As the UK’s number one skincare brand, No7 has an undeniable heritage of launching market-leading and clinically proven products time and time again. I am extremely proud of the work that No7 has done, together with Boots, to bring expert skincare to the high street, offering customers world-class scientific innovation at affordable prices.”